Australian Mother Threatens Class-Action Against TGA Over Zoloft
This article was originally published in PharmAsia News
The mother of an Australian girl alleged to have become suicidal after taking Pfizer's Zoloft (sertraline) is considering a suit against the country's drug regulator. The mother settled her $59,000 suit against the physician who prescribed the drug. She said she was contemplating a class-action suit against the Therapeutic Goods Administration on grounds it did not advise the public anti-depressant drugs have risks. The suit against the doctor alleged he falsely promoted Zoloft, the daughter attempted suicide, and the mother had to quit her job to care for the 16 year old. It was discovered the girl had a genetic defect that caused her to have adverse reactions to the sertraline. (Click here for more
You may also be interested in...
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.
The German biotech has developed its COVID-19 vaccine in record-breaking time, but artificial intelligence could help accelerate drug discovery over the longer term.
Denmark’s biotech Genmab has dropped the AXL targeted antibody-drug conjugate, enapotamab vedotin from early clinical development, and is focusing its resources on other therapeutic programs.